Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Toho Picked as Single Wholesaler for LEO Pharma’s Dovonex
October 26, 2022
- Daiichi Sankyo’s FLT3 Inhibitor Gets FDA’s Priority Review for 1st Line AML
October 26, 2022
- Chugai Logs Bumper Earnings in January-September on New Products, Exports to Roche
October 25, 2022
- Bayer Launches Xarelto Tablets 2.5 mg for PAD as Single-Channel Product
October 25, 2022
- LEO Pharma to Take Over Dovonex Distribution, Set Up Solo Sales Regime in Japan
October 25, 2022
- GSK Seeks Japan Approval of RSV Vaccine
October 24, 2022
- Genmab to Branch Out into 2nd Disease Area beyond Cancer, Specifics to Be Unveiled Next Year: CEO
October 24, 2022
- Approval by January Unlikely for SanBio’s Lead Cell Therapy as Production Review Stalls
October 21, 2022
- Sunovion to Divest US Market Rights of 2 Drugs to Lupin for US$75 Million
October 21, 2022
- Kyowa Kirin Assigns Bone Metabolism Specialists to Promote Crysvita in Japan
October 20, 2022
- Bayer to Halt Sale of PAH Med Ventavis in Japan over Nebulizer Supply Issue
October 20, 2022
- MSD Started Work to Develop Easier-to-Swallow Form of Lagevrio: Exec
October 20, 2022
- Sumitomo Aiming to Take the Lead in Developing Universal Flu Vaccines
October 19, 2022
- Chugai’s Integrated Drug Discovery Research Center Completed in Yokohama
October 19, 2022
- Kyowa Kirin Files Intas-Licensed Mitomycin for Cancer Use in Japan
October 19, 2022
- Bayer to Distribute Xarelto Tablets 2.5 mg via Single Wholesaler
October 18, 2022
- Fuji Pharma Files 1st Biosimilar Out of Alvotech Collaboration
October 18, 2022
- Takeda’s Dengue Vaccine Secures Positive Opinion in EU
October 18, 2022
- Mitsubishi Tanabe’s Neuromyelitis Optica Spectrum Disorder Med Approved in Taiwan
October 18, 2022
- Shionogi Eyes FY2024 Japan Filing of Regeneration-Inducing Medicine
October 17, 2022
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…